Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 1998, p. 427-436, Vol. 36, No. 2
Max von Pettenkofer-Institut für
Hygiene und Medizinische Mikrobiologie,
Received 20 June 1997/Returned for modification 31 July
1997/Accepted 4 November 1997
For the standardization of serological tests for Lyme borreliosis
(LB) in Europe, the influence of the heterogeneity of Borrelia burgdorferi sensu lato must be assessed in detail. For this study four immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assays
(ELISAs) with octyl-
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Impact of Strain Heterogeneity on Lyme Disease
Serology in Europe: Comparison of Enzyme-Linked Immunosorbent Assays
Using Different Species of Borrelia burgdorferi Sensu
Lato
-D-glucopyranoside extracts of
strains PKo (Borrelia afzelii), PBi (Borrelia
garinii), and PKa2 and B31 (both B. burgdorferi sensu
stricto) were compared. Strains PKo, PBi, and PKa2 at the passages used
for antigen preparations abundantly expressed outer surface protein C
(OspC), whereas strain B31 at the passage used for antigen preparation
did not express OspC. Sera (all from Germany) from 222 patients with
clinically defined LB of all stages, 133 blood donors, and 458 forest
workers were tested. None of the forest workers had symptoms consistent
with LB at the time that the samples were collected. For IgM tests, receiver operating characteristic curves demonstrated that
discrimination between sera from patients and blood donors was best
with strain PKo and worst with strain B31. The discriminatory abilities
of the four IgG ELISAs were similar in a diagnostically reasonable specificity range (90 to 100%). More than 20% of the sera from forest
workers reacted strongly in the PKo IgG ELISA (optical density value,
>1.5; other assays, less than 8%). Western blots of the sera with the
most discrepant ELISA results revealed almost exclusive reactivity with
p17. This highly immunogenic antigen is only expressed by strain PKo.
This observation might be important for the development of assays
enabling discrimination between asymptomatic or previous infection and
active disease.
*
Corresponding author. Mailing address: Max von
Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie
der Ludwig-Maximilians-Universität München,
Pettenkoferstr. 9a, D-80336 Munich, Germany. Phone: 0049-89-51605225. Fax: 0049-89-51604757. E-mail:
hauser{at}m3401.mpk.med.uni-muenchen.de.
Journal of Clinical Microbiology, February 1998, p. 427-436, Vol. 36, No. 2
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|